Anti-mask and anti-vaccine fervor are causing an overload of the healthcare system and leading to increased mortality and morbidity. Three publications recently released, including a randomized controlled trial, evaluate community masking on COVID-19 spread.
Guest
Michael Hogue, PharmD, FAPhA, FNAP
Dean, Loma Linda University
Redeem your CPE or CME credit here!
References and resources: Abaluck J, Kwong L, Styczynski A, et al. The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh. Available at: https://www.poverty-action.org/publication/impact-community-masking-covid-19-cluster-randomized-trial-bangladesh. Bazant M, Bush J. A guideline to limit indoor airborne transmission of COVID-19. Proceedings of the National Academy of Sciences Apr 2021, 118 (17) e2018995118; DOI: 10.1073/pnas.2018995118. Center for Disease Control. Morbidity and mortality weekly report: MMWR. [Atlanta, GA]: US Dept of Health, Education, and Welfare, Public Health Service, Center for Disease Control. Sept 10, 2021.
Continuing Education Information:
Learning Objectives:
1. Describe the Abaluck et al trial, including benefits and applications
2. Describe the evidence base for public health interventions, including difficulties for randomized controlled studies
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-338-H01-P
Initial release date: 09/28/21
Expiration date: 09/28/22
Dr. Hogue reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here!